SCHEMBL8624326

SCHEMBL8624326

CCOC(=O)C1C(=O)c2ccccc2C1c1ccc(O[Si](C)(C)C(C)(C)C)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.39
KMT2A Q03164 6/20 0.39
MAPT P10636 6/20 0.39
NPSR1 Q6W5P4 4/20 0.39
HTT P42858 2/20 0.39
MAPK1 P28482 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 9/20 0.38
CYP1A2 P05177 4/20 0.38
CYP2C19 P33261 4/20 0.38
CYP2C9 P11712 2/20 0.38
KDM4E B2RXH2 2/20 0.38
GLA P06280 1/20 0.38
CYP2D6 P10635 2/20 0.37
TSHR P16473 3/20 0.36
MDM2 Q00987 1/20 0.36
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7532653 0.86 FFAR1 (0.41) HTTL3MBTL1SMN1; SMN2ALDH1A1CYP2D6
SCHEMBL8620891 0.81 MAPT (0.45) MEN1KMT2AMAPTNPSR1HTT
SCHEMBL8621700 0.79 EDNRA (0.52) MEN1KMT2ANPSR1MAPK1LMNA
SCHEMBL3584871 0.71 MEN1 (0.46) MEN1KMT2AMAPTNPSR1HTT
SCHEMBL8626850 0.69 ALDH1A1 (0.47) MEN1KMT2AMAPTNPSR1HTT
SCHEMBL7534053 0.68 EDNRA (0.73)
SCHEMBL18244750 0.67 PREP (0.40) MEN1KMT2AMAPTHTTALDH1A1
SCHEMBL6768784 0.67 PREP (0.37) MEN1KMT2AHTTMAPK1LMNA
SCHEMBL7177838 0.67 PREP (0.37) MEN1KMT2AHTTMAPK1LMNA
SCHEMBL7531863 0.67 ALDH1A1 (0.63) MEN1KMT2AMAPTNPSR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5817693-A Endothelin receptor antagonists SMITHKLINE BEECHAM CORPORATION 1998-10-06 US disclosed
US-5719182-A TREATING HYPERTENSION, RENAL FAILURE, CEREBROVASCULAR DISEASE SMITHKLINE BEECHAM CORPORATION (US) 1998-02-17 US disclosed